Press releaseGlobe Newswire
Tiziana Life Sciences
TLSA · NASDAQ
$1.01+$0.00 (+0.00%)TodayMarket closed ·
Prev close $1.01
Latest news
- Press releaseGlobe Newswire
Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab
- Press releaseGlobe Newswire
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
- NewsVandana Singh
Why Is Tiziana Life Sciences Stock Gaining Thursday?
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
- NewsVandana Singh
Tiziana Life Sciences Says Imaging Results Show Neuroinflammation Reduction in Rare Neurodegenerative Condition
- Press releaseGlobe Newswire
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsAvi Kapoor
Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
- NewsBadar Shaikh
Lucid Is Now Shipping Adapters That Let Customers Access Elon Musk-Led Tesla's Supercharger Network
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
Tiziana Life Sciences Formulab Featured On News Channel
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease
- Press releaseGlobe Newswire
Tiziana Life Sciences not to engage in capital raising activities for the immediate future
- NewsRishabh Mishra
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus
- NewsRishabh Mishra
Elon Musk Says Amazon Founder Jeff Bezos Urged Tesla, SpaceX Investors To Dump Stakes, Predicting Trump's Loss
- Press releaseGlobe Newswire
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.